For the first time in more than 25 years, respect for the biopharmaceutical industry rose dramatically in 2020 due in large part due to the unprecedented delivery of vaccines against Covid-19.
For the first time in more than 25 years, respect for the biopharmaceutical industry rose dramatically in 2020 due in large part due to the unprecedented delivery of vaccines against Covid-19.